One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

XEC is also an offshoot of omicron, the widely spread variant that formed in 2021. According to experts, it has some of omicron’s features, too — like less severe symptoms and easy transmissibility.

Health data show that COVID-19 still surpasses all other infectious respiratory illnesses as a cause of severe illness, ...

Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week apart.

Yet many people don’t seem to recognize this—and this is a missed opportunity. Helping people to rethink side effects as ...

COVID-19 levels in the United States are high and rising, flu season is approaching quickly, and RSV cases are already ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against serious COVID-19 impacts.

The Vaccine Innovation Center at Korea University College of Medicine (VIC-K, Director Heejin Cheong) has entered into a full-scale collaboration with global pharmaceutical company Moderna to ...

Recent pipeline developments, including new cancer treatments and promising vaccine results ... In the below chart, we can see that Eliquis and Prevnar generated around $13 billion in 2023 ...

On the other hand, by late fall the major variants may have changed, rendering the vaccine less effective, said Peter Marks, the FDA’s top vaccine official, at a briefing Aug. 23. He urged everyone ...

The U.S. Food and Drug Administration recently green-lit new 2024-25 COVID-19 vaccinations ahead of the fall and winter seasons, when respiratory viruses spread more rapidly within communities.